Anaerobic infection therapy.

Area of Science:

• Microbiology
• Infectious Diseases
• Surgical Infections

Background:

• Anaerobic bacteria, especially the Bacteroides fragilis group, are primary pathogens in abdominal surgical infections.
• Surgical intervention is the cornerstone of therapy, with antibiotics serving an adjunctive role in managing these infections.

Purpose of the Study:

• To review current therapeutic regimens for anaerobic infections, focusing on antibiotic selection.
• To highlight critical considerations for antimicrobial therapy against anaerobes in surgical settings.

Main Methods:

• Review of established and emerging antibiotic strategies for anaerobic infections.
• Discussion of factors influencing antibiotic choice, including infection source and patient population.
• Emphasis on the importance of anaerobic cultures for resistance surveillance.

Main Results:

• Various antibiotic combinations (cephalosporins, aminoglycosides, aztreonam, quinolones with metronidazole or clindamycin) are effective.
• Monotherapy options include cefoxitin, cefotetan, carbapenems, and beta-lactamase inhibitors.
• Limited development of novel antimicrobials active against anaerobes and data gaps in critically ill patients.

Conclusions:

• Antibiotic selection must account for infection source, local resistance data, and patient status.
• Hyperbaric oxygen may be a valuable adjunct in specific anaerobic infection cases.
• Continued surveillance and research into effective anaerobic antimicrobial therapies are warranted.